A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis
Clinical trial NCT06042920 · TERMINATED
Trial details
- NCT number
- NCT06042920
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-09
- Primary completion
- 2025-04-25
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.